Streetbeat News

Price Targets

MELI

Citigroup analyst Joao Pedro Soares has reaffirmed a Buy rating on MercadoLibre (NASDAQ:MELI) and increased the price target from $1550 to $1900, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 11:20 am

C

Wolfe Research analyst Steven Chubak has upgraded Citigroup (NYSE:C) from Peer Perform to Outperform and set a price target of $58.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 10:57 am

ROK

UBS analyst Chris Snyder has upgraded Rockwell Automation (NYSE:ROK) from Neutral to Buy and increased the price target from $305 to $360.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 10:55 am

UNM

JP Morgan analyst Jimmy Bhullar has upgraded Unum Group (NYSE:UNM) from Neutral to Overweight and set a price target of $55.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 10:54 am

VZ

Keybanc analyst Brandon Nispel has upgraded Verizon Communications (NYSE:VZ) from Sector Weight to Overweight and set a price target of $45.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 10:52 am

GSK

Jefferies analyst Peter Welford has upgraded GSK (NYSE:GSK) from Hold to Buy and increased the price target from $38.5 to $48, indicating a positive outlook for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 10:46 am

JMIA

Morgan Stanley analyst Luke Holbrook has upgraded Jumia Technologies (NYSE:JMIA) from Underweight to Equal-Weight and increased the price target from $3 to $3.6.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 10:44 am

OPRX

Barclays analyst Stephanie Davis has initiated coverage on OptimizeRx (NASDAQ: OPRX) with an Equal-Weight rating and set a price target of $15 for the stock.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 10:41 am

PHR

Barclays analyst Stephanie Davis has initiated coverage on Phreesia (NYSE:PHR), a healthcare software company, with an Overweight rating and set a price target of $29 for the stock.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 10:40 am

LH

Barclays analyst Stephanie Davis has initiated coverage on Laboratory Corp (NYSE:LH) with an Equal-Weight rating and set a price target of $222 for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 10:38 am